City

Dallas (1)

Condition

Advanced Squamous Non Small Cell Lung Cancer (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Akeso (1)

University of Texas Southwestern Medical Center (1)

Collaborator

Intervention

afatinib + prednisone (1)

ak112, carboplatin, paxlitaxel (1)

tislelizumab, carboplatin, paxlitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

advanced squamous non small cell lung cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Squamous Non Small Cell Lung Cancer Trial (AK112, Carboplatin, Paxlitaxel, Tislelizumab, Carboplatin, Paxlitaxel)

Not yet recruiting

Advanced Squamous Non Small Cell Lung Cancer

AK112, Carboplatin, Paxlitaxel
Tislelizumab, Carboplatin, Paxlitaxel

(no location specified)

Apr 21, 2023

Advanced Squamous Non Small Cell Lung Cancer Trial in Dallas (Afatinib + Prednisone)

Recruiting

Advanced Squamous Non Small Cell Lung Cancer

Afatinib + Prednisone

Dallas, Texas

UT Southwestern Medical Center

Jun 28, 2022